Showing results (1201-1210 of 1,419) with videos related to

Sort By:
Pageof 142
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 18, 2004
Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressorsHolger Laux, Raju Tomer, Michael T Mader, et al.
Inflammatory Bowel Diseases|September 18, 2010
Strong overexpression of CXCR3 axis components in childhood inflammatory bowel diseaseSebastian Schroepf, Roland Kappler, Stephan Brand, et al.
Geobiology|April 23, 2013
Authigenic iron oxide proxies for marine zinc over geological time and implications for eukaryotic metallome evolutionL J Robbins, S V Lalonde, M A Saito, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjectsMaki Nakayama, Kristen McDaniel, Lisa Fitzgerald-Miller, et al.
Plos One|September 12, 2013
The respiratory arsenite oxidase: structure and the role of residues surrounding the rieske clusterThomas P Warelow, Muse Oke, Barbara Schoepp-Cothenet, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 11, 2024
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastomaSalih Demir, Alina Hotes, Tanja Schmid, et al.
International Journal of Molecular Sciences|January 11, 2024
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial VirusAdrien Le Rouzic, Jenna Fix, Robin Vinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimeraE G Trehu, J W Mier, J S Dubois, et al.
Mabs|June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitroHaolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
International Journal of Oncology|May 10, 2007
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?D Wuttig, D Kunze, S Fuessel, et al.
Pageof 142